The Effect of Guided Imagery in Children With Type 1 Diabetes Mellitus on Glucose Levels and on Glycemic Control
NCT ID: NCT01567254
Last Updated: 2015-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2012-04-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary Objective: To asses simultaneously the effect of listening to auditory guided imagery and blood glucose variability, compared to variability in blood glucose while listening to songs.
Secondary Objective To assess the effect of routine auditory guided imagery to glycemic control and quality of life in children with type 1 diabetes mellitus, compared to listening listening to songs.
Methods:
Subjects: 14 youth ages 7-16 years with type 1 diabetes mellitus , for at least 6 months, and not during the honey moon period will be recruited, and will be blindly randomized to receive intervention (auditory guided imagery group) or control (regular auditory music).
Protocol:
Design: A randomized Controlled Blinded Study Intervention: 14 randomly numbered CD's will be prepared at study initiation, half containing auditory guided imagery and half containing music.
Study protocol: After an initial check up, including HbA1C levels, and explanation of study procedures the participants will be given either the intervention or the control CD, to be used twice a day for five days. During this period continuous glucose monitoring will be performed. On days one and five the procedure will take place while the participants are connected to biofeedback. QOL questionnaires will be completed at the beginning of day one, or before.
In the second part of the study the children will use the intervention / control CD at home twice a week for 12 weeks. At the end of the study period they will again be evaluated, including HbA1C, and all subjects will again complete QOL questionnaires
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 Diabetes
NCT01600664
Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes Mellitus
NCT01191866
The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
NCT02131896
The Impact of Telehealthcare Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes
NCT03505268
Home and School Visits Intervention for Children With DM TYPE 1
NCT02137174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
14 auditory disks will be prepared ahead of study initiation, 7 with the guided imagery program and 7 with regular songs.
All will look similar from the outside. The disks will be numbered 01-14. Disks numbering will be performed by an investigator who is not part of treatment team, without knowing which disk contains which content. So that the team and participants are blinded to the disk content at initiation.
Children and parents will be aware of the type of auditory disk after initial auscultation at visit number 1.
The team will continue to be blinded to type of disk until end of study. 3. All participants will be aware at study initiation that they may receive the auditory guided imagery disk or a regular songs / story auditory disk.
4\. Visit no. 1:
1. Will be arranged on date of their regular clinic visit
2. Guidance to disk usage
3. Biofeedback for autonomic parameters assessment
4. Participants will be connected to the continuous glucose monitoring system (A system which the patient is blinded to glucose readings).
5. Participants and parents will fill QOL questionnaire \[The Diabetes Treatment Satisfaction Questionnaire (DTSQ) by Bradley C. et Al (16)\], if not filled before.
6. Participants will listen to disk for the first time in clinic, alone in a room with the parent
7. At this stage participants will be aware of the group they are in (treatment vs. control), but team is still unaware.
8. Participants will be able to come with brothers and parents and recreational activity will be available at site for all for entertainment 5. Visit no. 2-5: 6. Participants will listen to disk twice a day for the next four days alone in a room in our clinic. They will be able to come with brothers and parents, and recreational activity will be available at site for all for entertainment.
7\. 5th day visit:
a. Participants will listen to disk for the last times in clinic, alone in a room.
b. Participants will be disconnected from CGMS c. Biofeedback for autonomic parameters assessment 8. Participants will listen to disk at least twice a week, for additional 11 weeks, at their choice of time and day, and will record the specific time of listening on study chart 9. Visit no. 6:
1. Will be arranged on date of their regular clinic visit (12-14 weeks after visit no. 1)
2. Biofeedback for autonomic parameters assessment
3. Participants and parents will fill QOL questionnaires (The Diabetes Treatment Satisfaction Questionnaire (DTSQ) by Bradley C. et Al (16)
4. End of study 10. Data will be collected from charts from dates of visit no. 1 and visit no. 3 regarding: weight, height, BMI, 14 days average blood glucose levels, HbA1c.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
guided imaginary
7 children receiving auditory guided imagery disk
guided imaginary
Auditory guided imagery disk - will be prepared by Ronit Brooks, a clinical psychologist, who is engaged in guided imagery and by Livia Yanai, an art therapist.
music
6 children receiving music disk
music ONLY
music. It will be equal in length to the auditory guided imagery disk
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
guided imaginary
Auditory guided imagery disk - will be prepared by Ronit Brooks, a clinical psychologist, who is engaged in guided imagery and by Livia Yanai, an art therapist.
music ONLY
music. It will be equal in length to the auditory guided imagery disk
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Insulin requirements of more than 0.4 units/kg/day for at least 3 months
* Age 7-16 years
* Agreement of parents or guardian to participate in the study
* Agreement and wiliness of child to participate in the study
Exclusion Criteria
* Unable to understand Hebrew
* Hearing defect
* Attention deficit disorder
7 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assaf Harofeh MC
Dr. Marianna Rachmiel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariana Rachmiel, MD
Role: PRINCIPAL_INVESTIGATOR
Hassaf Haroffeh Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assaf Haroffeh Medical center
Ẕerifin, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
54/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.